Zealand Pharma A/S (ZEAL.CO)

DKK 446.1

(-1.26%)

Total Debt Summary of Zealand Pharma A/S

  • Zealand Pharma A/S's latest annual total debt in 2023 was 200.27 Million DKK , down -54.84% from previous year.
  • Zealand Pharma A/S's latest quarterly total debt in 2024 Q2 was 389.99 Million DKK , up 0.21% from previous quarter.
  • Zealand Pharma A/S reported annual total debt of 443.47 Million DKK in 2022, down -43.68% from previous year.
  • Zealand Pharma A/S reported annual total debt of 787.42 Million DKK in 2021, up 557.02% from previous year.
  • Zealand Pharma A/S reported quarterly total debt of 389.18 Million DKK for 2024 Q1, up 226.41% from previous quarter.
  • Zealand Pharma A/S reported quarterly total debt of 200.27 Million DKK for 2023 FY, down -54.84% from previous quarter.

Annual Total Debt Chart of Zealand Pharma A/S (2023 - 2007)

Historical Annual Total Debt of Zealand Pharma A/S (2023 - 2007)

Year Total Debt Total Debt Growth
2023 200.27 Million DKK -54.84%
2022 443.47 Million DKK -43.68%
2021 787.42 Million DKK 557.02%
2020 119.84 Million DKK 39.75%
2019 85.76 Million DKK 0.0%
2018 - DKK -100.0%
2017 135.73 Million DKK -59.15%
2016 332.24 Million DKK 6.16%
2015 312.95 Million DKK 14.98%
2014 272.17 Million DKK 0.0%
2013 - DKK 0.0%
2012 - DKK 0.0%
2011 - DKK 0.0%
2010 - DKK 0.0%
2009 - DKK 0.0%
2008 - DKK -100.0%
2007 6.11 Million DKK 0.0%

Peer Total Debt Comparison of Zealand Pharma A/S

Name Total Debt Total Debt Difference
ALK-Abelló A/S 765 Million DKK 73.82%
Bavarian Nordic A/S 145.3 Million DKK -37.834%
Genmab A/S 770 Million DKK 73.99%
Gubra A/S 71.43 Million DKK -180.36%
Novo Nordisk A/S 27 Billion DKK 99.258%
Orphazyme A/S - DKK -Infinity%
Pharma Equity Group A/S 30.22 Million DKK -562.701%